• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过Tc-99m GSA肝脏闪烁扫描术检测到的活体供肝肝移植后复发性丙型肝炎。

Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy.

作者信息

Kaibori Masaki, Ha-Kawa Sang Kil, Uchida Yoichiro, Ishizaki Morihiko, Hijikawa Takeshi, Saito Takamichi, Imamura Atsushi, Hirohara Junko, Uemura Yoshiko, Tanaka Koichi, Kamiyama Yasuo

机构信息

Department of Surgery, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan.

出版信息

Dig Dis Sci. 2006 Nov;51(11):2013-7. doi: 10.1007/s10620-006-9534-1. Epub 2006 Sep 15.

DOI:10.1007/s10620-006-9534-1
PMID:16977504
Abstract

Recurrence of hepatitis C virus (HCV) after living donor liver transplantation was investigated using technetium-99m- diethylenetriaminepentaacetic acid-galactosyl human serum albumin (Tc-99m-GSA) liver scintigraphy. Four patients with decompensated cirrhosis due to HCV infection were retrospectively reviewed in this study. Scintigraphy was performed to determine the hepatic uptake ratio of the tracer corrected for disappearance from the blood, as well as the maximal removal rate of the tracer by hepatocytes, as parameters of hepatic functional reserve. In all patients, serum HCV ribonucleic acid (RNA) was detected 3 months after transplantation. The corrected hepatic uptake ratio and removal rate showed little change after transplantation in two patients without the recurrence of HCV infection. In another two patients, these levels were decreased at 3 months after transplantation. In one patient, recurrent HCV infection was diagnosed by confirmatory histologic examination at 12 months after transplantation. In the other patient, both levels declined further at 8 months. Although treatment was initiated with a combination of interferon plus ribavirin, this patient died of progressive hepatic failure. In conclusion, a decrease in scintigraphic parameters at 3 months after transplantation suggests recurrent HCV infection affecting the graft. Tc-99m-GSA liver scintigraphy is a useful noninvasive method for evaluating graft functional reserve.

摘要

利用锝-99m-二乙三胺五乙酸-半乳糖基人血清白蛋白(Tc-99m-GSA)肝脏闪烁扫描术对活体供肝移植后丙型肝炎病毒(HCV)的复发情况进行了研究。本研究对4例因HCV感染导致失代偿性肝硬化的患者进行了回顾性分析。进行闪烁扫描以确定经血液中示踪剂消失校正后的肝脏摄取率,以及肝细胞对示踪剂的最大清除率,作为肝功能储备的参数。所有患者在移植后3个月均检测到血清HCV核糖核酸(RNA)。在2例未发生HCV感染复发的患者中,校正后的肝脏摄取率和清除率在移植后变化不大。在另外2例患者中,这些指标在移植后3个月时下降。1例患者在移植后12个月经组织学检查确诊为HCV感染复发。另一例患者的这两个指标在8个月时进一步下降。尽管开始使用干扰素加利巴韦林联合治疗,但该患者死于进行性肝功能衰竭。总之,移植后3个月闪烁扫描参数的下降提示复发性HCV感染影响移植物。Tc-99m-GSA肝脏闪烁扫描术是评估移植物功能储备的一种有用的非侵入性方法。

相似文献

1
Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy.通过Tc-99m GSA肝脏闪烁扫描术检测到的活体供肝肝移植后复发性丙型肝炎。
Dig Dis Sci. 2006 Nov;51(11):2013-7. doi: 10.1007/s10620-006-9534-1. Epub 2006 Sep 15.
2
Usefulness of TC-99M GSA liver scintigraphy for the assessment of recurrent hepatitis C after living-donor liver transplantation: a case report.锝-99m 半胱氨酸乙酰甘氨酸肝闪烁扫描术在评估活体肝移植后丙型肝炎复发中的应用:病例报告
Transplant Proc. 2008 Oct;40(8):2837-9. doi: 10.1016/j.transproceed.2008.07.020.
3
Detection of Portal Vein Stenosis by Technetium-99m-Diethylenetriaminepentaacetic Acid-Galactosyl Human Serum Albumin Liver Scintigraphy after Living-Donor Liver Transplantation.活体肝移植后用锝-99m-二乙三胺五乙酸-半乳糖基人血清白蛋白肝脏闪烁显像检测门静脉狭窄
Hepatogastroenterology. 2014 Jun;61(132):1063-7.
4
Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation.活体肝移植后通过Tc-99m-GSA闪烁扫描术评估供体肝脏的再生情况。
Dig Dis Sci. 2008 Mar;53(3):850-5. doi: 10.1007/s10620-007-9902-5. Epub 2007 Aug 4.
5
Usefulness of Tc-99m-GSA scintigraphy for liver surgery.Tc-99m-GSA 闪烁扫描在肝外科中的应用价值。
Ann Nucl Med. 2011 Nov;25(9):593-602. doi: 10.1007/s12149-011-0520-0. Epub 2011 Jul 29.
6
Usefulness of TC-99M GSA liver scintigraphy for the evaluation of liver regeneration in donors after living-donor liver transplantation.锝-99m 肝特异性胶体显像(TC-99M GSA)在活体肝移植供体肝再生评估中的应用价值
Transplant Proc. 2008 Oct;40(8):2457-9. doi: 10.1016/j.transproceed.2008.07.019.
7
Predictability of Tc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure.Tc-半乳糖基人血清白蛋白闪烁显像对肝切除术后肝衰竭的预测性。
AJR Am J Roentgenol. 2018 Jan;210(1):158-165. doi: 10.2214/AJR.17.18411. Epub 2017 Oct 12.
8
Assessment of liver graft function and regeneration by galactosyl-human serum albumin (99mTc-GSA) liver scintigraphy in adult living-donor liver transplantation.用半乳糖基人血清白蛋白(99mTc-GSA)肝脏闪烁扫描术评估成人活体肝移植中肝移植肝功能及再生情况。
Clin Transplant. 2009 Mar-Apr;23(2):271-7. doi: 10.1111/j.1399-0012.2008.00933.x. Epub 2009 Dec 16.
9
Safety of hepatectomy for living donors as evaluated using asialoscintigraphy.使用去唾液酸闪烁扫描术评估活体供肝肝切除术的安全性。
Transplant Proc. 2004 Oct;36(8):2239-42. doi: 10.1016/j.transproceed.2004.08.056.
10
Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve.锝-99m标记半乳糖基人血清白蛋白闪烁扫描术在评估肝功能储备中的应用。
J Clin Gastroenterol. 1999 Jun;28(4):329-33. doi: 10.1097/00004836-199906000-00009.

引用本文的文献

1
Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation.用于肝脏恶性肿瘤及移植中功能评估与诊疗的核医学成像
World J Gastroenterol. 2014 May 14;20(18):5375-88. doi: 10.3748/wjg.v20.i18.5375.

本文引用的文献

1
Preemptive therapy for hepatitis C virus after living-donor liver transplantation.活体肝移植后丙型肝炎病毒的抢先治疗
Transplantation. 2004 Nov 15;78(9):1308-11. doi: 10.1097/01.tp.0000142677.12473.e5.
2
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.美国成人活体供肝移植后丙型肝炎受者的患者及移植物存活率
Liver Transpl. 2004 Mar;10(3):340-6. doi: 10.1002/lt.20090.
3
Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults.
丙型肝炎感染相关肝病:成人尸体供肝和活体供肝肝移植后的复发模式及结局
Transplantation. 2004 Jan 27;77(2):210-4. doi: 10.1097/01.TP.0000101007.59478.8B.
4
Living donor liver transplantation and hepatitis C.
Clin Liver Dis. 2003 Aug;7(3):651-65, viii. doi: 10.1016/s1089-3261(03)00058-8.
5
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.肝移植后慢性丙型肝炎患者使用干扰素-α 2b加利巴韦林:一项随机研究。
Gastroenterology. 2003 Mar;124(3):642-50. doi: 10.1053/gast.2003.50095.
6
Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation.成人活体肝移植术后早期快速进展性胆汁淤积性丙型肝炎再感染及移植物丢失
Am J Transplant. 2003 Feb;3(2):239-40. doi: 10.1034/j.1600-6143.2003.00035.x.
7
Living donor liver transplantation in Kyoto, 2001.2001年京都的活体供肝肝移植
Clin Transpl. 2001:195-201.
8
The association between hepatitis C infection and survival after orthotopic liver transplantation.丙型肝炎感染与原位肝移植术后生存率之间的关联。
Gastroenterology. 2002 Apr;122(4):889-96. doi: 10.1053/gast.2002.32418.
9
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.肝移植后早期使用干扰素和利巴韦林治疗预防丙型肝炎复发
Transplant Proc. 2001 Feb-Mar;33(1-2):1355-7. doi: 10.1016/s0041-1345(00)02508-2.
10
HCV-related fibrosis progression following liver transplantation: increase in recent years.
J Hepatol. 2000 Apr;32(4):673-84. doi: 10.1016/s0168-8278(00)80231-7.